Study points to link between antidepressant use in pregnancy and autism in children

July 19, 2017
Credit: CC0 Public Domain

Children exposed to antidepressants during pregnancy seem to be at a slightly higher risk of autism than children of mothers with psychiatric disorders who were not treated with antidepressants during pregnancy, finds a study published in The BMJ today.

However, the researchers stress that the absolute risk of autism was small, so these results should not be considered alarming.

Depression is common in women of childbearing age, and in Europe 3-8% of pregnant women are prescribed antidepressants during .

Several studies have reported associations between antidepressant use during pregnancy and autism in offspring. But it is not clear whether this is due to the underlying illness, antidepressant drugs, or other unmeasured factors.

Such factors (known as confounding) can introduce bias and affect the results of a study, making it difficult to draw firm conclusions about cause and effect.

In a bid to minimise the effects of confounding - and better understand the reasons behind this association - a research team led by Dheeraj Rai at the University of Bristol applied a range of analytical methods to a large Swedish population.

They analysed data from 254,610 individuals aged 4-17, including 5,378 with autism, living in Stockholm in 2001-11 who were born to mothers who did not take antidepressants and did not have any psychiatric disorder, mothers who took antidepressants during pregnancy, or mothers with who did not take antidepressants during pregnancy.

Of the 3,342 children exposed to antidepressants during pregnancy, 4.1% (136) had a diagnosis of autism compared with 2.9% (353) in 12,325 children not exposed to antidepressants whose mothers had a history of a psychiatric disorder.

There was no evidence of any increased risk of autism in children whose fathers were prescribed antidepressants during the mothers' pregnancy.

The results of the various analyses seemed to be consistent with each other, say the authors, suggesting that the association between antidepressant use in pregnancy and autism might not be fully explained by confounding.

They point to some study limitations, such as lack of detailed measures of severity of depression. However key strengths were the large sample size and the range of analyses carried out to minimise bias.

So what should families and doctors making decisions about antidepressants during pregnancy make of such results?

It is important to note that the absolute risk was small (over 95% of women in the study who took antidepressants during pregnancy did not have a child with autism), stress the authors.

They estimate that, even if the association between antidepressant use and autism is causal, only 2% of cases would be prevented if no women with psychiatric disorders used antidepressants during pregnancy.

They call for "a balanced discussion in relation to clinical decision making in the light of evolving but yet inconsistent evidence" and say "it is important to continue investigation of possible underlying biological mechanisms that could help us to better understand the aetiology of autism."

In a linked editorial, Diana Schendel at Aarhus University in Denmark says the findings of this study "should be viewed through the kaleidoscope of possible causes of autism" and calls for future studies to be better powered, and include measures of maternal disease severity, more reliable measures of antidepressant use, and, ideally genetic markers.

She points to the "reassuring study message" that more than 95% of women in the study who took did not have a child with .

Although such a small risk within a population might seem too high from an individual's perspective, "it must be carefully weighed against the substantial health consequences associated with untreated depression," she concludes.

Explore further: No statistically significant risk of ID in children from mothers using antidepressants

More information: BMJ (2017). www.bmj.com/content/358/bmj.j2811

BMJ (2017). www.bmj.com/content/358/bmj.j3388

Related Stories

No statistically significant risk of ID in children from mothers using antidepressants

July 12, 2017
A study published by JAMA Psychiatry reports no evidence of an association between intellectual disability in children and mothers who took antidepressant medication during pregnancy when other mitigating factors, such as ...

Article examines studies on antidepressants, autism spectrum disorders

April 17, 2017
A new article published by JAMA Pediatrics reviews and analyzes a small collection of studies on fetal exposure to antidepressants and autism spectrum disorders (ASDs).

Study: Antidepressant use in early pregnancy does not increase autism, ADHD risk in kids

April 18, 2017
A study led by Indiana University suggests that mothers' use of antidepressants during early pregnancy does not increase the risk of their children developing autism or attention deficit hyperactivity disorder, conditions ...

Study finds no increased risk of autism, ADHD with prenatal antidepressant exposure

January 5, 2016
- An analysis of medical records data from three Massachusetts health care systems finds no evidence that prenatal exposure to antidepressants increases the risk for autism and related disorders or for attention-deficit hyperactivity ...

Antidepressants during pregnancy associated with childhood language disorders

October 12, 2016
Mothers who purchased antidepressants at least twice during pregnancy had a 37-percent increased risk of speech and/or language disorders among their offspring compared to mothers with depression and other psychiatric disorders ...

Recommended for you

Signaling pathway may be key to why autism is more common in boys

October 17, 2017
Researchers aiming to understand why autism spectrum disorders (ASD) are more common in boys have discovered differences in a brain signaling pathway involved in reward learning and motivation that make male mice more vulnerable ...

Whole genome sequencing identifies new genetic signature for autism

October 12, 2017
Autism has genetic roots, but most cases can't be explained by current genetic tests.

Mum's immune response could trigger social deficits for kids with autism

October 10, 2017
The retrospective cohort study of 220 Australian children, conducted between 2011-2014, indicates that a "an immune-mediated subtype" of autism driven by the body's inflammatory and immunological systems may be pivotal, according ...

Largest study to date reveals gender-specific risk of autism occurrence among siblings

September 25, 2017
Having one child with autism is a well-known risk factor for having another one with the same disorder, but whether and how a sibling's gender influences this risk has remained largely unknown.

Faulty cell signaling derails cerebral cortex development, could it lead to autism?

September 20, 2017
As the embryonic brain develops, an incredibly complex cascade of cellular events occur, starting with progenitors - the originating cells that generate neurons and spur proper cortex development. If this cascade malfunctions ...

Predicting atypical development in infants at high risk for autism?

September 12, 2017
New research from the Sackler Institute for Developmental Psychobiology at Columbia University Medical Center (CUMC) identifies a potential biomarker that predicts atypical development in 1- to 2-month-old infants at high ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.